Your gift is 100% tax deductible.
Stages of Melanoma Skin Cancer
After someone is diagnosed with melanoma, doctors will try to figure out if it has spread, and if so, how far. This process is called staging.
The stage of a cancer describes how much cancer is in the body. It helps determine how serious the cancer is and how best to treat it. Doctors also use a cancer’s stage when talking about survival statistics.
How is the stage determined?
The staging system most often used for melanoma is the American Joint Committee on Cancer (AJCC) TNM system, which is based on 3 key pieces of information.
T describes the main (primary) tumor, including how deeply the cancer has grown into the skin and whether the cancer is ulcerated.
- Tumor thickness (Breslow measurement): Melanomas less than 1 millimeter (mm) thick have a very small chance of spreading. As the melanoma becomes thicker, it has a greater chance of spreading.
- Ulceration: This is a sore over the melanoma. Melanomas that are ulcerated tend to have a worse outlook.
N describes spread to nearby lymph nodes.
M describes spread (metastasis) to distant parts of the body. Melanoma can spread almost anywhere in the body, but the most common sites of spread are the lungs, liver, brain, bones, skin, and lymph nodes in other parts of the body.
Numbers or letters after T, N, and M provide more details about each of these factors. Higher numbers mean the cancer is more advanced.
Once a person’s T, N, and M categories have been determined, this information is combined in a process called stage grouping to assign an overall stage.
The earliest melanomas are stage 0 (melanoma in situ) and then range from stages I through IV. Some stages are split further, using capital letters (A, B, etc.). As a rule, the lower the number, the less the cancer has spread. And within a stage, an earlier letter means a lower stage.
Clinical stage vs. pathological stage
There are 2 main types of staging for melanoma.
- The clinical stage is based on the results of physical exams, biopsies, and any imaging tests that have been done. The clinical stage can be used to help determine if more tests are needed, to help plan treatment, and to give an idea of a person’s outlook.
- The pathological stage, also called the surgical stage, might be determined if surgery is done after the skin biopsy to remove more of the area around the skin tumor or check nearby lymph nodes for cancer.
Sometimes the pathological stage might be different from the clinical stage. For example, it might become clear during surgery that the cancer has grown farther than what could be seen on imaging tests.
To learn more about how cancer is staged, see Cancer Staging.
Stages of melanoma
Below is a simplified version of the clinical stages of melanoma in the most recent TNM system. If your cancer has been pathologically staged, it is best to talk to your doctor about your specific stage.
Melanoma staging can be very complex, so if you have any questions about the stage of your cancer or what it means, ask your doctor to explain it to you in a way you understand.
Stage grouping: Tis, N0, M0
The cancer is only in the epidermis, the outermost skin layer, and has not grown any deeper (Tis). There are no signs the cancer has spread to nearby lymph nodes (N0) or to distant parts of the body (M0).
This stage is also known as melanoma in situ.
Stage grouping: T1 or T2a, N0, M0
The main tumor is no more than 2 mm thick and might or might not be ulcerated (T1 or T2a). There are no signs the cancer has spread to nearby lymph nodes (N0) or to distant parts of the body (M0).
Stage I is further divided into stages IA and IB, based on tumor thickness and whether it’s ulcerated.
Stage grouping: T2b-T4, N0, M0
The main tumor is more than 1 mm thick (T2b or T3) and might be thicker than 4 mm (T4). It might or might not be ulcerated. There are no signs the cancer has spread to nearby lymph nodes (N0) or to distant parts of the body (M0).
Stage II is further divided into stages IIA, IIB, and IIC, based on tumor thickness and whether it’s ulcerated.
Stage grouping: Any T, N1-N3, M0
The main tumor can be any thickness, and it might or might not be ulcerated (any T). The cancer has spread to nearby lymph nodes and/or it has spread to very small areas of nearby skin (satellite tumors) or to skin lymphatic channels around the tumor (N1, N2, or N3). There are no signs the cancer has spread to distant parts of the body (M0).
Stage grouping: Any T, any N, M1a-M1d
The main tumor can be any thickness, and it might or might not be ulcerated (any T). The cancer might or might not have spread to nearby lymph nodes (any N). The cancer has spread to distant parts of the body, such as:
- Areas of skin or lymph nodes in other parts of the body (M1a)
- The lungs (M1b)
- Any other organs outside the central nervous system (M1c)
- The central nervous system, including the brain, spinal cord, and the coverings of the brain and spinal cord (M1d)
- Written by
- References
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
American Joint Committee on Cancer. Melanoma of the Skin. In: AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017: 563-585.
Buzaid AC, Gershenwald JE. Tumor, node, metastasis (TNM) staging system and other prognostic factors in melanoma. UpToDate. 2026. Accessed at https://www.uptodate.com/contents/tumor-node-metastasis-tnm-staging-system-and-other-prognostic-factors-in-cutaneous-melanoma on May 6, 2026.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Melanoma: Cutaneous. Version 2.2026. Accessed at https://www.nccn.org on May 6, 2026.
Last Revised: August 12, 2026
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
American Cancer Society Emails
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.


